Peter M Smith-Jones

Title: Innovations of Peter M Smith-Jones in Antibody Labeling

Introduction

Peter M Smith-Jones is a notable inventor based in Port Jefferson, NY (US). He has made significant contributions to the field of biochemistry, particularly in the area of antibody labeling. His innovative approach has the potential to enhance the efficacy of treatments for neoplastic diseases.

Latest Patents

Peter M Smith-Jones holds a patent for a method titled "One-step labeling of antibodies to high specific activity with actinium-225." This patent describes a one-step method for chelating actinium-225 to a construct that includes a chelator linked to a biomolecule, such as an antibody, via a bifunctional ligand. The method aims to increase the radiochemical yield of the actinium-225-chelant-biomolecule complex while performing the chelation at a physiological temperature of about 37°C. Additionally, the patent outlines the production of high specific activity actinium-225 complexes and their pharmaceutical applications in treating neoplastic diseases.

Career Highlights

Throughout his career, Peter M Smith-Jones has focused on developing innovative methods that bridge the gap between chemistry and medicine. His work has been instrumental in advancing the field of targeted therapies, particularly in oncology.

Collaborations

Peter has collaborated with esteemed colleagues such as David A Scheinberg and Michael R McDevitt. These collaborations have further enriched his research and contributed to the development of groundbreaking methodologies in the field.

Conclusion

Peter M Smith-Jones is a pioneering inventor whose work in antibody labeling has the potential to revolutionize treatment options for cancer patients. His innovative methods and collaborations highlight the importance of interdisciplinary approaches in advancing medical science.